when sequential high dose drug-radiation cytoreductive regimens are employed , the interval between chemotherapy and total body irradiation ( tbi ) can markedly influence both toxicity in rapid cell renewal systems and the probability of successfully ablating normal and malignant hemopoietic stem cells .
C0007634
cell
C0018956
hemopoietic stem cells